According to Alembic Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.24758. At the end of 2023 the company had a P/S ratio of 2.49.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.49 | 28.23% |
2022 | 1.94 | -37.5% |
2021 | 3.11 | -21.75% |
2020 | 3.97 | 57.42% |
2019 | 2.52 | -12.55% |
2018 | 2.89 | -13.76% |
2017 | 3.35 | -9.14% |
2016 | 3.68 | -14.71% |
2015 | 4.32 | 5.39% |
2014 | 4.10 | 86.07% |
2013 | 2.20 |